ATE500324T1 - Inhibitoren der enzymaktivität der endooligopeptidase a (eopa) und ihre verwendungen - Google Patents
Inhibitoren der enzymaktivität der endooligopeptidase a (eopa) und ihre verwendungenInfo
- Publication number
- ATE500324T1 ATE500324T1 AT03812536T AT03812536T ATE500324T1 AT E500324 T1 ATE500324 T1 AT E500324T1 AT 03812536 T AT03812536 T AT 03812536T AT 03812536 T AT03812536 T AT 03812536T AT E500324 T1 ATE500324 T1 AT E500324T1
- Authority
- AT
- Austria
- Prior art keywords
- eopa
- activity
- heopa
- application
- endooligopeptidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0205000 | 2002-12-09 | ||
BR0305688A BR0305688A (pt) | 2003-12-05 | 2003-12-05 | Processo para a determinação da estrutura primária do rna mensageiro codificante para a endooligopeptidase a humana (heopa) [genbank acc n°af217798] e da sua sequência protéica [genbank acc n° aaf24516], para a determinação do gene da eopa humana, e para a produção da eopa humana recombinante; processo de geração de anticorpos anti-heopa; processo de padronização e utilização de substratos sintéticos para a determinação das propriedades bioquìmicas e proteolìticas da heopa; processo de identificação e produção de inibidores da eopa, obtenção de anticorpos com atividade inibitória sobre a atividade catalìtica e sobre a interação com oligopeptìdeos; método de identificação dessa proteìna em patologias congênitas, infecciosas e degenerativas do sistema nervoso central, e método de determinação do papel da eopa em processos imunológicos; método de diagnóstico imuno-quìmico e/ou enzimático, para a prevenção, evolução de patologias, prognóstico ou tratamento de doenças congênitas, infecciosas e degenerativas do sistema nervoso central; uso das propriedades de interação de ligantes com o centro ativo da eopa atuando quer como inibidores da sua ação enzimática e/ou alterando a sua associação com outras proteìnas intracelulares, úteis no tratamento de patologias neurológicas, psiquiátricas e degenerativas |
PCT/BR2003/000189 WO2004053052A2 (en) | 2002-12-09 | 2003-12-08 | HUMAN RECOMBINANT ENDOOLIGOPEPTIDASE A (hEOPA) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE500324T1 true ATE500324T1 (de) | 2011-03-15 |
Family
ID=37719837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03812536T ATE500324T1 (de) | 2002-12-09 | 2003-12-08 | Inhibitoren der enzymaktivität der endooligopeptidase a (eopa) und ihre verwendungen |
Country Status (8)
Country | Link |
---|---|
US (2) | US20070031830A1 (de) |
EP (1) | EP1578953B1 (de) |
JP (1) | JP5272114B2 (de) |
AT (1) | ATE500324T1 (de) |
AU (1) | AU2003302901A1 (de) |
CA (1) | CA2507811C (de) |
DE (1) | DE60336265D1 (de) |
WO (1) | WO2004053052A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1774023B1 (de) * | 2004-06-25 | 2013-05-01 | Washington University School Of Medicine | Marker für hirnschädigung |
EP2205249B1 (de) | 2007-09-28 | 2018-11-07 | Intrexon Corporation | Therapeutische genschalterkonstrukte und bioreaktoren zur expression biotherapeutischer moleküle und ihre verwendung |
BRPI1004231A2 (pt) * | 2010-11-09 | 2013-03-12 | Universidade Federal De São Paulo- Unifesp | mÉtodo e kit para diagnàstico de condiÇÕes neuropsiquiÁtricas, mÉtodo para avaliaÇço de tratamentos de condiÇÕes neuropsiquiÁtricas e mÉtodo de identificaÇço de fÁrmacos potencialmente éteis no tratamento de condiÇÕes neuropsiquiÁtricas |
US10115661B2 (en) | 2013-02-08 | 2018-10-30 | Qualcomm Incorporated | Substrate-less discrete coupled inductor structure |
WO2014158275A1 (en) * | 2013-03-29 | 2014-10-02 | Intel IP Corporation | Establishment of connection to the internet in cellular network |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6171790B1 (en) * | 1998-05-01 | 2001-01-09 | Incyte Pharmaceuticals, Inc. | Human protease associated proteins |
US6406891B1 (en) * | 1998-09-28 | 2002-06-18 | Board Of Regents, The University Of Texas System | Dual RT procedure for cDNA synthesis |
JP5058403B2 (ja) * | 2000-06-27 | 2012-10-24 | シスメックス株式会社 | Ck−mb活性測定法およびck−mb活性測定試薬 |
JP2002065266A (ja) * | 2000-08-28 | 2002-03-05 | Teijin Ltd | 気道特異的トリプシン様酵素およびその利用法 |
-
2003
- 2003-12-08 WO PCT/BR2003/000189 patent/WO2004053052A2/en active Application Filing
- 2003-12-08 US US10/538,071 patent/US20070031830A1/en not_active Abandoned
- 2003-12-08 DE DE60336265T patent/DE60336265D1/de not_active Expired - Lifetime
- 2003-12-08 CA CA2507811A patent/CA2507811C/en not_active Expired - Fee Related
- 2003-12-08 AU AU2003302901A patent/AU2003302901A1/en not_active Abandoned
- 2003-12-08 JP JP2004557687A patent/JP5272114B2/ja not_active Expired - Fee Related
- 2003-12-08 EP EP03812536A patent/EP1578953B1/de not_active Expired - Lifetime
- 2003-12-08 AT AT03812536T patent/ATE500324T1/de not_active IP Right Cessation
-
2008
- 2008-04-14 US US12/102,821 patent/US20090017042A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070031830A1 (en) | 2007-02-08 |
CA2507811C (en) | 2013-11-05 |
WO2004053052A2 (en) | 2004-06-24 |
WO2004053052A3 (en) | 2006-08-03 |
DE60336265D1 (de) | 2011-04-14 |
AU2003302901A8 (en) | 2004-06-30 |
EP1578953A2 (de) | 2005-09-28 |
JP2006524983A (ja) | 2006-11-09 |
AU2003302901A1 (en) | 2004-06-30 |
US20090017042A1 (en) | 2009-01-15 |
EP1578953A4 (de) | 2007-08-08 |
CA2507811A1 (en) | 2004-06-24 |
JP5272114B2 (ja) | 2013-08-28 |
EP1578953B1 (de) | 2011-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE502005009389D1 (de) | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern | |
WO2007070671A3 (en) | Therapeutic methods for inhibiting tumor growth with dll4 antagonists | |
DK1066380T3 (da) | Opløselig T-cellereceptor | |
NO2011003I1 (no) | Dimensk fusjonsprotein bestående av de ligandbindende cfomener av de ekstacellulære deler av human type I interieukm-1 reseptor (IL-1R1) og IL-1 reseptor hjelpeprotein bundet (IL-I-RAcP) bundet i tinje til Fc-delen av humant IgG | |
IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
WO2006002161A3 (en) | Modulators of odorant receptors | |
NO20074374L (no) | Fremgangsmate for fremstilling av polypeptidblandinger ved anvendelse av hydrogenolyse | |
DK1572967T3 (da) | IL-1-receptorbaserede antagonister og fremgangsmåder til fremstilling og anvendelse deraf | |
WO2005087811A3 (en) | Estrogen receptors and methods of use | |
DE602005019495D1 (de) | Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung | |
ATE465171T1 (de) | Neue chemokine bindende peptide, die die biologische aktivität dieser chemokine modulieren | |
ATE500324T1 (de) | Inhibitoren der enzymaktivität der endooligopeptidase a (eopa) und ihre verwendungen | |
MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
DK1234025T3 (da) | Humane enzymer fra metalloproteasefamilien | |
DE60332579D1 (de) | Prozess zur Immobilisierung von Polypeptiden über die Carboxylgruppe des C-terminus | |
ATE373717T1 (de) | Pde8a und seine verwendung | |
ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
DE60330680D1 (de) | Transferrin-fusionsproteinbibliotheken | |
ATE466880T1 (de) | Cytokinpolypeptidvarianten | |
DE60032161D1 (de) | P-glycoproteine und ihre verwendungen | |
SE9801530D0 (sv) | Method for screening | |
AU2003260546A8 (en) | Device for the presentation of peptides or proteins, method for the preparation and use thereof | |
GB0426960D0 (en) | TGR-3 like protein receptor | |
ATE312941T1 (de) | Test auf phosphoamidase | |
ATE415415T1 (de) | Bicyclische oligopeptide und deren verwendung als glucagon rezeptorantagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |